The Novavax COVID-19 vaccine recently received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for individuals 18 and older, making Novavax the fourth COVID-19 vaccine to receive either authorization or full approval from the FDA. Background: The Use of Immortalized Fetal Cell LinesBriefly, several immortalized cell lines have been developed over time from donated embryonic tissue, some of which was derived from elective abortion procedures. [5] Nevertheless, the distant association of the fetal cell lines with abortion gives pause to many religious objectors. Novavax’s EUA and supporting evidence should provide sufficient information for religious objectors to obtain the Novavax COVID-19 vaccine. [16] The benefits that potentially could come from the EUA of the Novavax COVID-19 vaccine is not a recommendation or endorsement by Epstein Becker Green of the Novavax vaccine over the Pfizer, Moderna, or Johnson & Johnson vaccine.

Source: Washington Post August 11, 2022 17:13 UTC